Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Marijuana

Terra Tech Corp. CEO, Derek Peterson, Discusses Recent News and Provides an Outlook for the Company in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, April 20, 2017 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and Terra Tech Corp. (OTC QX:TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, announced today that a new audio interview with the Company is now available. The interview can be heard at http://smallcapvoice.com/blog/4-12-17-smallcapvoice-interview-with-terra-tech-corp-trtc.

Derek Peterson, CEO of Terra Tech, called in to SmallCapVoice.com to go over the exciting news for Terra Tech Corp. Topics covered in the interview include the recent White House comments on the cannabis industry, market penetration in California, the overwhelming successes in Nevada, the steady growth for Edible Gardens and more.

In the interview, regarding the current administration’s stance on cannabis, Peterson stated, “If we were having this conversation two years ago it wouldn’t be what it is today, but last November we had eight of the nine pieces of national legislation go through. That shows overwhelming support for an expanded …

Continue Reading

Posted in Client News| Tagged , , , |

4-12-17 SmallCapVoice Interview with Terra Tech Corp (TRTC)

Terra Tech Corp (TRTC)

Terra Tech Corp. CEO, Derek Peterson, called in to SmallCapVoice.com, Inc. to share his thoughts on the new White House administration’s stance on medical and recreational marijuana, the ramping up of TRTC’s efforts in Nevada, and the explosive growth the Company has had in the California market to date. Peterson also talked about their subsidiary Edible Gardens. Edible Gardens continues to provide meaningful revenues and steady cash flow adding over 100 new retailers in 2016.

Terra Tech Corp. (TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, MediFarm LLC and GrowOp Technology. Blüm’s retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. Blüm offers a broad selection of medical cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary …

Continue Reading

Posted in Interviews| Tagged , , |

AXIM Biotechnologies, Inc. and API Develop Marinol Alternative

AXIM Biotechnologies, Inc.

Medical marijuana has presented life-changing treatment options for patients around the world, but with strict laws in many regions preventing the use of such pharmaceutical alternatives, progress has been gradual. There is still significant stigma surrounding the effects of medical marijuana and its use in a clinical treatment setting. Despite the many positive studies associated with these products, opposition persists in many sectors of the market. Companies such as AXIM Biotechnologies, Inc. (OTCQX: AXIM) have long been at the forefront of medical marijuana research and development, facing opposition from lobbyists and other detractors who seek to keep the status quo within the pharmaceutical industry. Until recently, Insys Therapeutics was one of those companies.

In the past, Insys Therapeutics has been active in the opposition of general marijuana legalization, donating $500,000 to a group called Arizonans for Responsible Drug Policy in the summer of 2016. The group launched a campaign …

Continue Reading

Posted in Articles| Tagged , , , |

Medical Marijuana, Inc. Positioned Perfectly as New Studies Showcase How CBD Oil is Effective for Treating Epileptic Children

Medical Marijuana, Inc. (MJNA)

According to the Epilepsy Foundation, the incidence of epilepsy is highest in young children and older adults. There are currently 2.2 million people who are believed to have epilepsy in the United States alone, and many of those suffering are children whose symptoms prevent them from going to school and leading normal childhoods. Epileptic seizures can range from mild and infrequent to being characterized by violent and near-constant convulsions. The problem with many existing treatments for epilepsy is that they quite often come with debilitating side effects, are ineffective, or a combination of both. Children are even more severely affected by many of these negative side effects than adult patients, and their young age may limit the treatment options available to them.

Medical marijuana is an increasingly popular treatment option for children and adults with epilepsy. Around the world, there have been promising case studies on the positive effects …

Continue Reading

Posted in Articles| Tagged , , , |

HempMeds Continues Domestic and International Growth in 2017

MJNA

HempMeds is a subsidiary of Medical Marijuana, Inc. (MJNA), a publicly traded company that sells a variety of cannabis-based products in the United States and abroad. MJNA has made international headlines with its recent status as an exclusive importer of cannabidiol oil products to Brazil. In February of 2017, the Brazilian government approved a prescription for HempMeds’ Real Scientific Hemp Oil as a treatment for multiple sclerosis. Multiple sclerosis is a debilitating disease that affects the central nervous system, causing pain and a variety of other neuromuscular issues. With Real Scientific Hemp Oil, patients can experience the life-changing benefits of cannabidiol oil without the harmful side effects that accompany most pain medications.

The 2017 decision made by the Brazilian government’s National Health Surveillance Agency (ANVISA) is the first import approved for RSHO as a treatment for multiple sclerosis. More than 2.5 million people suffer from multiple sclerosis worldwide, which …

Continue Reading

Posted in Articles| Tagged , , , , |

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., Discusses Recent News and Events in a New Audio Interview at SmallCapVoice.com

AUSTIN, Texas, Feb. 27, 2017 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink: MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, is now available. The interview can be heard at http://smallcapvoice.com/blog/2-10-17-smallcapvoice-interview-with-medical-marijuana-inc-mjna/.

Stuart W. Titus, PhD, the CEO of Medical Marijuana, Inc., called in to SmallCapVoice.com to provide the listening audience with his personal insights into the Company’s recent news and the feedback from his recent trip to speak to investors at The Money Show Orlando about cannabis industry trends and investment opportunities and how biotech companies are producing cannabinoid-based pharmaceuticals that have the potential to improve the daily life of millions across the globe.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and …

Continue Reading

Posted in Client News| Tagged , , , |